Aktis Oncology, Inc. (AKTS)

19.48 +0.90 (+4.87%) USD  |  NASDAQ  |  Jun 11, 16:00
19.48 0.00 (0.00%) After-Hours: 19:26
More

Aktis Oncology Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for AKTS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Total Expenses (Quarterly) Data

View and export this data back to 2024. Start Trial.
Date Value
March 31, 2026 --
December 31, 2025 --
Date Value
March 31, 2025 --
December 31, 2024 --

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
MetaVia, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade
Vericel Corp. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
Revenue (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Gross Profit Margin (Quarterly) Upgrade
Profit Margin (Quarterly) Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade